Folate deficiency modifies the risk of CIN3+ associated with DNA methylation levels: a nested case-control study from the ASCUS-COL trial
ABSTRACT: Purpose: To our knowledge, there are very few studies evaluating if the levels of folate modify the risk of cervical intraepithelial neoplasia grade 2 and higher (CIN2+ and CIN3+) associated with the levels of HPV genome methylation, two cofactors related to single carbon metabolism and in...
- Autores:
-
Agudelo Fernández, María Cecilia
Agudelo Gamboa, Samuel
Ramírez Pineda, Arianis Tatiana
Castañeda Vanegas, Kelly Melisa
Garcés Palacio, Isabel Cristina
Sánchez Vásquez, Gloria
Lorincz, Attila
Zea, Arnold H.
Piyathilake, Chandrika
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2024
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/45268
- Acceso en línea:
- https://hdl.handle.net/10495/45268
- Palabra clave:
- Atypical Squamous Cells of the Cervix
Células Escamosas Atípicas del Cuello del Útero
Case-Control Studies
Estudios de Casos y Controles
DNA Methylation
Metilación de ADN
Folic Acid
Ácido Fólico
Folic Acid Deficiency
Deficiencia de Ácido Fólico
Uterine Cervical Dysplasia
Displasia del Cuello del Útero
https://id.nlm.nih.gov/mesh/D065309
https://id.nlm.nih.gov/mesh/D016022
https://id.nlm.nih.gov/mesh/D019175
https://id.nlm.nih.gov/mesh/D005492
https://id.nlm.nih.gov/mesh/D005494
https://id.nlm.nih.gov/mesh/D002578
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by/4.0/
| Summary: | ABSTRACT: Purpose: To our knowledge, there are very few studies evaluating if the levels of folate modify the risk of cervical intraepithelial neoplasia grade 2 and higher (CIN2+ and CIN3+) associated with the levels of HPV genome methylation, two cofactors related to single carbon metabolism and independently associated with cervical cancer in previous studies. We conducted a case-control study nested in a three-arm randomized clinical pragmatic trial (ASCUS-COL trial) to evaluate the risk of CIN3+ associated with methylation levels according to serum folate concentrations. Methods: Cases (n = 155) were women with histologically confirmed CIN2+ (113 CIN2, 38 CIN3, and 4 SCC) and controls were age and follow-up time at diagnosis-matched women with histologically confirmed ≤ CIN1 (n = 155), selected from the 1122 hrHPV + women of this trial. The concentrations of serum folate were determined by the radioimmunoassay SimulTRAC-SNB-VitaminB12/Folate-RIAKit and the methylation levels by the S5 classifier. Stepwise logistic regression models were used to estimate the association between folate or methylation levels and CIN2+ or CIN3+. The joint effect of folate levels and methylation on the risk of CIN3+ was estimated using combinations of categorical stratifications. Results: Folate levels were significantly lower in women with CIN3+ than in other diagnostic groups (p = 0.019). The risk of CIN3+ was eight times higher (OR 8.9, 95% CI 3.4-24.9) in women with folate deficiency and high methylation levels than in women with normal folate and high methylation levels (OR 1.4, 95% CI 0.4-4.6). Conclusion: High methylation and deficient folate independently increased the risk of CIN3+ while deficient folate combined with high methylation was associated with a substantially elevated risk of CIN3+. |
|---|
